For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Dongkook Pharmaceutical Co., Ltd.

Calculating rank

USPTO Granted Patents = 25

% Expired Patents = 12.0

EPO Patents = 3

Trademarks = 5

Forward Citations = 87

Loading Chart...

Loading Chart...

96 inventors (with patents filed for the assignee):

Jin Kyu Park (7 out of 16 patents)

Sang Ki Rhee (4 out of 9 patents)

Sung Ki Seo (4 out of 4 patents)

4. Yong Hyun Kim (4 out of 42 patents)

5. Hyeung Geun Park (3 out of 8 patents)

6. Won Hun Ham (3 out of 4 patents)

7. Hee Doo Kim (3 out of 5 patents)

8. Jeong Hoon Kim (3 out of 77 patents)

9. Wan Soo Kim (3 out of 63 patents)

10. Sang Sup Jew (3 out of 7 patents)

11. Young Choong Kim (3 out of 3 patents)

12. Young Hoon Jung (3 out of 3 patents)

13. Chi Hyoung Yoo (3 out of 3 patents)

14. Hee Man Kim (3 out of 4 patents)

15. Doo Yeon Lim (3 out of 3 patents)

Core Competencies:

Donepezil

Voriconazole

Asiatic Acid

Neuronal Damage

Sustained-Release

Recombinant Hormones

Teicoplanin

Analgesic Analogues

Affinity Chromatography

Drug Delivery

Aclacinomycins

Pyrrolizine Derivatives

25 patents: Sort by Forward Citations

1. 10085941 - Pharmaceutical composition for parenteral administration, containing donepezil (2018-10-02),

2. 9168282 - Method for treating neuronal damage and neurological diseases (2015-10-27),

3. 8575344 - Process for preparing voriconazole by using new intermediates (2013-11-05),

4. 8541030 - Preparation method of sustained-release microcapsules having initial burst inhibiting property and the microcapsules thereby (2013-09-24),

5. 7244591 - Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone (2007-07-17),

6. 7192743 - Method of producing teicoplanin (2007-03-20),

7. 6274559 - Liver protection or treatment agents comprising asiatic acid derivatives as the active component (2001-08-14),

8. 6169112 - Medicines for treating dementia or cognitive disorder, which comprises asiatic acid derivatives (2001-01-02),

9. 6143900 - Stereoselective synthesis of oxazoline derivative (2000-11-07),

10. 6127546 - Process for the preparation of oxazoline compound (2000-10-03),

11. 6071898 - Asiatic acid derivatives having modified A-ring (2000-06-06),

12. 5855904 - Biodegradable sustained release preparation for treating periodontitis (1999-01-05),

13. 5849915 - Buprenorphine analgesic analogues (1998-12-15),

14. 5834437 - Asiatic acid derivatives its manufacturing method and dermatological (1998-11-10),

15. 5817808 - Process for preparing benzodiazepine derivatives (1998-10-06),

Company Overview

Dongkook Pharmaceutical Co., Ltd. is a prominent South Korean company specializing in the development and manufacturing of pharmaceuticals and healthcare products. The organization focuses on innovative drug formulations and therapeutic solutions, particularly in the fields of cardiology, oncology, and infectious diseases. With a commitment to research and development, Dongkook aims to enhance patient care and improve health outcomes through advanced medical technologies and effective treatments.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

25 Patents

#191 in Seoul

#522 in South Korea

#25,729 in the World

Seoul, South Korea

Dongkook Pharmaceutical Co., Ltd.

Forward Citations = 87

96 inventors:

Jin Kyu Park (7 out of 16 patents)

Sang Ki Rhee (4 out of 9 patents)

Sung Ki Seo (4 out of 4 patents)

4. Yong Hyun Kim (4 out of 42 patents)

5. Hyeung Geun Park (3 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dongkook Pharmaceutical Co., Ltd.. Retrieved from https://idiyas.com/company/dongkook-pharmaceutical-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…